Erudio Healtherudio.com
Clinical trial · no report yet · Phase 3
PERYTON trial: what clinicians have said so far
PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy
- NCT04642027 ↗
- Recruiting
- University Medical Center Groningen
- Focused size, estimated: 1–150 verified statements
We haven't built an HCP commentary report on PERYTON (prostate cancer with biochemical failure after radical prostatectomy; tests a strategy, not a drug) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on PERYTON so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Indexed so far | |
|---|---|
| 5 posts on X | |
| 1 podcast episode |
The trial
ClinicalTrials.gov- Official title
- PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy of Biochemical Failure After Radical Prostatectomy for Prostate Cancer
- Phase
- Phase 3
- Status
- Recruiting
- Conditions
- Prostate Cancer; Cancer Recurrence
- Interventions
- Conventional sEBRT; Hypofractionated sEBRT
- Arms
- Conventional · Active comparator
- Hypofractionation · Experimental
- Enrollment
- 538 (estimated)
- Primary outcomes
- 5-year progression-free survival
- Sponsor
- University Medical Center Groningen with Dutch Cancer Society
- Start
- Sep 1, 2020
- Primary completion
- Sep 1, 2029 (estimated)
- Results posted
- No
- Registry record
- NCT04642027 · updated Feb 28, 2024
Publications
linked from the registry- Staal FHE, Janssen J, Oprea-Lager DE, Engelen AM, van Limbergen EJ, Smeenk RJ, de Jong MAA, Budiharto TCG, Jacobs I, Haverkort DMAD, Brouwer CL, Ng Wei Siang K, Langendijk JA, Verzijlbergen JF, de Jong IJ, Noordzij W, Aluwini S. Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Based Clinical Target Volume Delineation Guideline for Postprostatectomy Salvage Radiation Therapy: The PERYTON Guideline. Int J Radiat Oncol Biol Phys. 2024 Mar 1;118(3):688-696. doi: 10.1016/j.ijrobp.2023.09.016. Epub 2023 Sep 18. PubMed 37729971
- Staal FHE, Janssen J, Brouwer CL, Langendijk JA, Ng Wei Siang K, Schuit E, de Jong IJ, Verzijlbergen JF, Smeenk RJ, Aluwini S. Phase III randomised controlled trial on PSMA PET/CT guided hypofractionated salvage prostate bed radiotherapy of biochemical failure after radical prostatectomy for prostate cancer (PERYTON-trial): study protocol. BMC Cancer. 2022 Apr 15;22(1):416. doi: 10.1186/s12885-022-09493-5. PubMed 35428210